CEO SUMMARY: It is ironic that, after the federal Centers for Medicare and Medicaid Services (CMS) enacted the deepest price cuts to the Part B Clinical Laboratory Fee Schedule in more than 50 years, a U.S. Senator now asks CMS why it will pay billions more for lab testing. The question from Iowa Senator Chuck
Senator Asks: Are Lab Test Payments Too High?
By Joseph Burns, from the Volume XXVI No. 2 – February 4, 2019 issue